Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000375335 | SCV000334662 | benign | not specified | 2015-08-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000378189 | SCV000482292 | likely benign | Ornithine carbamoyltransferase deficiency | 2018-02-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV000375335 | SCV000520980 | benign | not specified | 2016-08-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000378189 | SCV000631859 | benign | Ornithine carbamoyltransferase deficiency | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313837 | SCV000849237 | benign | Inborn genetic diseases | 2016-11-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mendelics | RCV000378189 | SCV001141820 | benign | Ornithine carbamoyltransferase deficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Gen |
RCV000083395 | SCV000115481 | pathogenic | not provided | no assertion criteria provided | not provided | Converted during submission to Pathogenic. | |
Sing |
RCV000378189 | SCV000853171 | uncertain significance | Ornithine carbamoyltransferase deficiency | 2017-06-07 | no assertion criteria provided | curation | |
Natera, |
RCV000378189 | SCV001453007 | benign | Ornithine carbamoyltransferase deficiency | 2020-04-03 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003925087 | SCV004739667 | benign | OTC-related disorder | 2020-04-21 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |